Explaining paranoia: cognitive and social processes in the occurrence of extreme mistrust.


Journal

BMJ mental health
ISSN: 2755-9734
Titre abrégé: BMJ Ment Health
Pays: England
ID NLM: 9918521385306676

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 08 09 2023
accepted: 26 10 2023
medline: 13 11 2023
pubmed: 10 11 2023
entrez: 9 11 2023
Statut: ppublish

Résumé

Paranoia-incorrectly thinking that others are deliberating trying to harm you-causes distress, undermines social interactions and leads to withdrawal. It presents across multiple psychiatric diagnoses. The primary aim was to determine the extent that cognitive and social processes may explain paranoia. The secondary aim was to identify explanatory factors that distinguished paranoia and social anxiety. 10 382 UK adults, quota sampled to match the population for age, gender, ethnicity, income and region, participated in a non-probability survey. All participants completed a paranoia measure and assessments of cognitive and social processes. Structural equation modelling was conducted. 2586 (24.9%) participants described being mistrustful of other people. 1756 (16.9%) participants wanted help to trust more. 66.7% of variance in paranoia was explained by a model comprising (in descending order of importance): within-situation defence behaviours, negative images, negative self-beliefs, discrimination, dissociation, aberrant salience, anxiety sensitivity, agoraphobic distress, worry, less social support, agoraphobic avoidance, less analytical reasoning and alcohol use. All explanatory factors were associated with paranoia and social anxiety. Ten factors were more closely associated with paranoia than social anxiety, including discrimination, hallucinations, negative images, aberrant salience and alcohol use. Nine factors were more closely associated with social anxiety, including less positive self-belief, an external locus of control, worry and less analytical reasoning. Multiple causes are likely to be involved in paranoia. Cognitive and social processes may explain a high degree of paranoia. Multiple clear targets for intervention to reduce paranoia are identified.

Sections du résumé

BACKGROUND BACKGROUND
Paranoia-incorrectly thinking that others are deliberating trying to harm you-causes distress, undermines social interactions and leads to withdrawal. It presents across multiple psychiatric diagnoses.
OBJECTIVE OBJECTIVE
The primary aim was to determine the extent that cognitive and social processes may explain paranoia. The secondary aim was to identify explanatory factors that distinguished paranoia and social anxiety.
METHODS METHODS
10 382 UK adults, quota sampled to match the population for age, gender, ethnicity, income and region, participated in a non-probability survey. All participants completed a paranoia measure and assessments of cognitive and social processes. Structural equation modelling was conducted.
FINDINGS RESULTS
2586 (24.9%) participants described being mistrustful of other people. 1756 (16.9%) participants wanted help to trust more. 66.7% of variance in paranoia was explained by a model comprising (in descending order of importance): within-situation defence behaviours, negative images, negative self-beliefs, discrimination, dissociation, aberrant salience, anxiety sensitivity, agoraphobic distress, worry, less social support, agoraphobic avoidance, less analytical reasoning and alcohol use. All explanatory factors were associated with paranoia and social anxiety. Ten factors were more closely associated with paranoia than social anxiety, including discrimination, hallucinations, negative images, aberrant salience and alcohol use. Nine factors were more closely associated with social anxiety, including less positive self-belief, an external locus of control, worry and less analytical reasoning.
CONCLUSIONS CONCLUSIONS
Multiple causes are likely to be involved in paranoia. Cognitive and social processes may explain a high degree of paranoia.
CLINICAL IMPLICATIONS CONCLUSIONS
Multiple clear targets for intervention to reduce paranoia are identified.

Identifiants

pubmed: 37945313
pii: bmjment-2023-300880
doi: 10.1136/bmjment-2023-300880
pmc: PMC10649488
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Br J Psychiatry. 2000 Apr;176:379-86
pubmed: 10827888
Psychol Med. 2023 Mar 17;:1-9
pubmed: 36927521
Br J Psychiatry. 2005 May;186:427-35
pubmed: 15863749
Am Sociol Rev. 1983 Apr;48(2):228-39
pubmed: 6859680
Schizophr Bull. 2006 Apr;32(2):366-77
pubmed: 16237200
Schizophr Bull. 2012 Jun;38(4):734-40
pubmed: 22496540
Aggress Behav. 2011 May-Jun;37(3):234-47
pubmed: 21404281
Psychol Med. 2008 Aug;38(8):1121-32
pubmed: 18533055
Schizophr Bull. 2015 Mar;41(2):391-9
pubmed: 25031222
Schizophr Bull. 2018 Apr 6;44(3):662-671
pubmed: 28981834
PLoS One. 2021 Feb 24;16(2):e0247037
pubmed: 33626089
Lancet Psychiatry. 2021 Aug;8(8):696-707
pubmed: 34246324
Psychol Med. 2020 Apr;50(5):771-780
pubmed: 30947766
Acta Psychiatr Scand. 2007 Oct;116(4):280-9
pubmed: 17803758
Behav Res Ther. 2013 Jan;51(1):7-14
pubmed: 23178174
Aust N Z J Psychiatry. 2021 Dec;55(12):1166-1177
pubmed: 33423520
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Psychol Med. 2006 Jun;36(6):749-59
pubmed: 16563204
Psychol Assess. 2010 Sep;22(3):688-701
pubmed: 20822281
J Pers Soc Psychol. 1999 Jun;76(6):972-87
pubmed: 10402681
Soc Psychiatry Psychiatr Epidemiol. 2019 Sep;54(9):1023-1044
pubmed: 31236631
Schizophr Bull. 2012 Mar;38(2):247-57
pubmed: 22258882
J Behav Ther Exp Psychiatry. 2014 Dec;45(4):454-8
pubmed: 25000504
Psychol Med. 2021 Jan;51(2):244-253
pubmed: 31744588
Psychol Med. 2009 Jun;39(6):881-7
pubmed: 18845010
Psychol Med. 2023 Mar;53(4):1233-1243
pubmed: 37010211
Psychol Med. 2013 Dec;43(12):2673-84
pubmed: 23531413
Lancet Psychiatry. 2016 Jul;3(7):685-92
pubmed: 27371990
J Psychiatr Res. 2021 Apr;136:460-467
pubmed: 33092867
JAMA Psychiatry. 2014 Sep;71(9):1049-57
pubmed: 25075799
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
J Nerv Ment Dis. 2005 May;193(5):309-15
pubmed: 15870614
J Pers Assess. 1990 Winter;55(3-4):610-7
pubmed: 2280326
Psychol Med. 2001 Oct;31(7):1293-306
pubmed: 11681555
Behav Res Ther. 1986;24(1):1-8
pubmed: 3947307
Psychiatry Res. 2014 Aug 30;218(3):348-52
pubmed: 24924485
Drug Alcohol Rev. 2003 Sep;22(3):309-15
pubmed: 15385225
J Affect Disord. 2020 Jul 1;272:84-90
pubmed: 32379625

Auteurs

Daniel Freeman (D)

Department of Experimental Psychology, University of Oxford, Oxford, UK daniel.freeman@psy.ox.ac.uk.
Oxford Health NHS Foundation Trust, Oxford, UK.

Bao Sheng Loe (BS)

University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH